ATNM

Actinium Pharmaceuticals Inc

Jun 03 • 04:00PM ET

1.16

-0.06 -4.92 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: ATOS GRCE INMB LTRN OTLK QNTM RNXT VERU XLO TLPH

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	3.10%	Shs Outstand	31.37M	Perf Week	-1.69%
Market Cap	36.39M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	30.40M	Perf Month	-3.33%
Enterprise Value	-4.22M	PEG	-	EPS next Q	-0.21	Inst Own	19.35%	Short Float	3.44%	Perf Quarter	-5.69%
Income	-23.47M	P/S	404.33	EPS this Y	24.08%	Inst Trans	-0.93%	Short Ratio	6.14	Perf Half Y	-15.33%
Sales	0.09M	P/B	15.80	EPS next Y	4.13%	ROA	-41.15%	Short Interest	1.05M	Perf YTD	-14.71%
Book/sh	0.07	P/C	0.86	EPS next 5Y	23.57%	ROE	-167.66%	52W High	1.95 -40.37%	Perf Year	-30.95%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-759.83%	52W Low	0.95 21.86%	Perf 3Y	-86.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-828.89%	Volatility	7.49% 5.79%	Perf 5Y	-86.35%
Dividend TTM	-	EV/Sales	-46.89	EPS Y/Y TTM	48.96%	Oper. Margin	-28346.67%	ATR (14)	0.07	Perf 10Y	-97.86%
Dividend Ex-Date	-	Quick Ratio	5.89	Sales Y/Y TTM	11.11%	Profit Margin	-26078.89%	RSI (14)	46.04	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.89	EPS Q/Q	65.39%	SMA20	-4.88%	Beta	-0.04	Target Price	5.75
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	-2.46%	Rel Volume	1.37	Prev Close	1.22
Employees	25	LT Debt/Eq	0.34	Earnings	May 11	SMA200	-14.30%	Avg Volume	170.64K	Price	1.16
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.44% -	Trades		Volume	232,399	Change	-4.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)